Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? (Q36304278)

13 August 2017

1 reference

title

Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? (English)

1 reference

13 August 2017

main subject

cardiovascular disease

1 reference

Sorin V Pislaru

1

1 reference

13 August 2017

Robert D Simari

series ordinal

2

1 reference

13 August 2017

publication date

1 March 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

138-144

1 reference

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Assessment of risks associated with cardiovascular gene therapy in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Recombinant gene expression in vivo within endothelial cells of the arterial wall

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Implantation of vascular grafts lined with genetically modified endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Indirect Monitoring of Endogenous Gene Expression by Positron Emission Tomography (PET) Imaging of Reporter Gene Expression in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Optical imaging of cardiac reporter gene expression in living rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Designing gene delivery vectors for cardiovascular gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0136

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0136

1 reference

13 August 2017

1 reference